Sec Form 13D Filing - Peterson James J filing for LANTRONIX INC (LTRX) - 2021-02-05

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 


 

 

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
   
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 4)
 
 
LANTRONIX, INC.
(Name of Issuer)
 
Common Stock, Par Value $0.0001 Per Share
(Title of Class of Securities)
 
516548203
(CUSIP Number)
 
 
James J. Peterson
c/o Peter Prescott, 30950 Rancho Viejo Road, Suite 100
San Juan Capistrano, CA 92675
(949) 248-9815
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 

February 4, 2021

(Date of Event Which Requires Filing of This Statement)
 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.¨

 

(Page 1 of 7 Pages)

 

 

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


 
CUSIP NO. 516548203 Page 2 of 7 Pages

 


 

 

1

NAME OF REPORTING PERSON

James J. Peterson

 

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY

&nbsp

4

SOURCE OF FUNDS

PF

 

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

&nbsp

¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
7

SOLE VOTING POWER

0

 

8

SHARED VOTING POWER

1,428,888 Shares of Common Stock

 

9

SOLE DISPOSITIVE POWER

0

 

10

SHARED DISPOSITIVE POWER

1,428,888 Shares of Common Stock

 

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

 

1,428,888 Shares of Common Stock

 

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

&nbsp

¨

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.0%*

 

14

TYPE OF REPORTING PERSON

IN

 

       

 

*Based upon 28,590,989 shares of Common Stock outstanding as of November 6, 2020 as disclosed in the Quarterly Report on Form 10-Q of the Issuer for the fiscal quarter ended September 30, 2020.

 

 


 
CUSIP NO. 516548203 Page 3 of 7 Pages

 

&nbsp


 

 

1

NAME OF REPORTING PERSON

Peterson Capital Group, LLC

 

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY

&nbsp

4

SOURCE OF FUNDS

AF

 

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

&nbsp

¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
7

SOLE VOTING POWER

0

 

8

SHARED VOTING POWER

1,428,888 Shares of Common Stock

 

9

SOLE DISPOSITIVE POWER

0

 

10

SHARED DISPOSITIVE POWER

1,428,888 Shares of Common Stock

 

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

 

1,428,888 Shares of Common Stock

 

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

&nbsp

¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.0%*

 

14

TYPE OF REPORTING PERSON

OO

 

       

 

*Based upon 28,590,989 shares of Common Stock outstanding as of November 6, 2020 as disclosed in the Quarterly Report on Form 10-Q of the Issuer for the fiscal quarter ended September 30, 2020.  

 

 


 
CUSIP NO. 516548203 Page 4 of 7 Pages

 

 


 

 

1

NAME OF REPORTING PERSON

Peterson Capital Group, Inc.

 

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY

&nbsp

4

SOURCE OF FUNDS

AF

 

5 CHECK BOX IF DIS CLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

&nbsp

¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

California

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
7

SOLE VOTING POWER

0

 

8

SHARED VOTING POWER

1,428,888 Shares of Common Stock

 

9

SOLE DISPOSITIVE POWER

0

 

10

SHARED DISPOSITIVE POWER

1,428,888 Shares of Common Stock

 

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

 

1,428,888 Shares of Common Stock

 

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

&nbsp

¨

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.0%*

 

14

TYPE OF REPORTING PERSON

CO

 

       

 

*Based upon 28,590,989 shares of Common Stock outstanding as of November 6, 2020 as disclosed in the Quarterly Report on Form 10-Q of the Issuer for the fiscal quarter ended September 30, 2020.  

 

 

 


 
CUSIP NO. 516548203 Page 5 of 7 Pages

 


 

This Amendment No. 4 ("Amendment No. 4") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on August 16, 2018 (the "Original Schedule 13D" and, sometimes, including amendments, herein called the "Schedule 13D") which was amended by Amendment No. 1 on October 3, 2018; Amendment No. 2 on April 13, 2020; and Amendment No. 3 on January 21, 2021, all with respect to the common stock, par value $0.0001 per share (the "Common Stock"), of Lantronix, Inc., a Delaware corporation (the "Issuer"). The Issuer's principal executive offices are located at 7535 Irvine Center Drive, Suite 100, Irvine, CA 92618. This Amendment No. 4 amends Items 5, 6 and 7 of the Schedule 13D as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 4 have the meanings set forth in the Schedule 13D.

 

  Item 5.    INTEREST IN SECURITIES OF THE COMPANY.

 

Paragraphs (a), (b), (c) and (e) of Item 5 of Schedule 13D are hereby set forth in their entirety as amended or restated:

 

  (a) See rows (11) and (13) of the cover pages to this Amendment No. 4 for the aggregate number of shares of Common Stock and percentage of Common Stock beneficially owned by each of the Reporting Persons. Percentages of the shares of Common Stock outstanding reported in this Amendment No. 4 are calculated based upon 28,590,989 shares of Common Stock outstanding as of November 6, 2020 as disclosed in the Quarterly Report on Form 10-Q of the Issuer for the fiscal quarter ended September 30, 2020.

 

  (b) See rows (7) through (10) of the cover pages to this Amendment No. 4 for the number of shares of Common Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

 

  (c) Since the most recent filing of Schedule 13D, the Reporting Persons effected the sale transactions set forth below:

 

 

Date of Transaction   Number of Shares   Price per Share
02/04/2021   10,000   $4.5514
02/03/2021   10,000   $4.6680
02/02/2021   10,000   $4.5750
02/01/2021   10,000   $4.4979
01/29/2021   10,000   $4.5164
01/28/2021   10,000   $4.4812
01/27/2021   10,000   $4.4958
01/26/2021   10,000   $4.7442
01/25/2021   10,000   $4.7400
01/22/2021   20,000   $4.7305
01/21/2021   10,000   $4.7100
01/20/2021   20,000   $4.8815

 

  (e) On February 4, 2021 the Reporting Persons ceased to be beneficial owners of more than five percent (5%) of the Common Stock.

 

 

 

 


 
CUSIP NO. 516548203 Page 6 of 7 Pages

 


 

  Item 6.    CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR R ELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

 

All the funds utilized by the Reporting Persons to purchase Common Stock were borrowed by Peterson Capital Group, LLC from James J. Peterson under loan documents containing standard provisions. Other than these loan provisions, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between Reporting Persons or between a Reporting Person and any other person with respect to any securities of the Issuer, including but not limited to transfer or voting of any Common Stock, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, divisions of profit or loss, the giving or withholding of proxies, or any pledge or other contingency the occurrence of which would give another person voting power over any securities of the Issuer.

 

 


 

  Item 7.    EXHIBITS.

 

Exhibit No.   Description  
Exhibit 1:   Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (previously filed by the Reporting Persons on August 18, 2018 as an exhibit to the Original Schedule 13D and incorporated herein by reference).
Exhibit 5:   Power of Attorney (previously filed by the Reporting Persons on January 21, 2021 as an exhibit to Amendment No. 3 of the Original Schedule 13D and incorporated herein by reference).

 

 


 
CUSIP NO. 516548203 Page 7 of 7 Pages

 

 

 

SIGNATURES

 

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

 

Date: February 4, 2021

 

/s/ James J. Peterson*
    Name: James J. Peterson
     
     
  PETERSON CAPITAL GROUP, LLC
     
  By: Peterson Capital Group, Inc., Manager
     
     
  By: /s/ James J. Peterson*
    Name: James J. Peterson
    Title: Chief Executive Officer
     
     
  PETERSON CAPITAL GROUP, INC.
     
     
  By:  /s/ James J. Peterson*
    Name: James J. Peterson
    Title: Chief Executive Officer
     
     

*By Nicholas J. Yocca, as attorney-in-fact for James J. Peterson